Revenue Breakdown
Composition ()
No data
Revenue Streams
Fonar Corp (FONR) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Management of Diagnostic Imaging Centers, accounting for 91.2% of total sales, equivalent to $24.77M. Another important revenue stream is Manufacturing and the servicing of medical equipment. Understanding this composition is critical for investors evaluating how FONR navigates market cycles within the Advanced Medical Equipment & Technology industry.
Profitability & Margins
Evaluating the bottom line, Fonar Corp maintains a gross margin of 40.11%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 12.26%, while the net margin is 10.25%. These profitability ratios, combined with a Return on Equity (ROE) of 4.07%, provide a clear picture of how effectively FONR converts its operational activities into shareholder value.
Comparative Benchmarking
In the context of the broader market, FONR competes directly with industry leaders such as ROMA and MED. With a market capitalization of $117.30M, it holds a significant position in the sector. When comparing efficiency, FONR's gross margin of 40.11% stands against ROMA's 6.96% and MED's 69.52%. Such benchmarking helps identify whether Fonar Corp is trading at a premium or discount relative to its financial performance.
